Skip to main content
SpringerLink
Log in

Quinidine in Atrial Fibrillation and Ventricular Tachycardia

  • Published:
Cardiac Electrophysiology Review

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brodsky MA, Chun JG, Podrid PJ, Douban S, Allen BJ, Cygan R. Regional attitudes of generalists, specialists and subspecialists about management of atrial fibrillation. Arch Int Med 1996;156:2553-2562.

    Google Scholar 

  2. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation 1990;82:1106-1116.

    Google Scholar 

  3. Morganroth J, Goin JE. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis. Circulation 1991;84(5):1977-1983.

    Google Scholar 

  4. Feld GK. Atrial fibrillation. Is there a safe and highly effective pharmacological treatment? Circulation 1990;82:2248-2250.

    Google Scholar 

  5. Salerno DM. Quinidine. Worse than adverse? Circulation 1991;84:2196-2198.

    Google Scholar 

  6. Grace AA, Camm AJ. Quinidine. N Engl J Med 1998;338(1): 35-45.

    Google Scholar 

  7. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:427-532.

    Google Scholar 

  8. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992;117:141-150.

    Google Scholar 

  9. Pritchett ELC. Management of atrial fibrillation. N Engl J Med 1992;326:1264-1271.

    Google Scholar 

  10. Naccarelli GV, Dorian P, Hohnloser SH, Coumel P. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. Am J Cardiol 1996;77:53A-59A.

    Google Scholar 

  11. Mason JW for the ESVEM Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-458.

    Google Scholar 

  12. Roden DM, Woolsley RL, Primm PK. Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patients care. Am Heart J 1986;111:1088-1093.

    Google Scholar 

  13. Bauman JL, Bauernfeind RA, Hoff JV, Strasberg B, Swiryn S, Rosen KM. Torsade de pointes due to quinidine: Observations in 31 patients. Am Heart J 1984;107:425-430.

    Google Scholar 

  14. Minardo JD, Heger JJ, Miles WM, Zipes DP, Prystowsky EN. Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy. N Engl J Med 1988;319(5):257-262.

    Google Scholar 

  15. Hohnloser SH, van de Loo A, Baedeker F. Efficacy and proarrhythmic hazards of pharmacologic cardoversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 1995;26:852-858.

    Google Scholar 

  16. Waktare JEP, Camm AJ. Atrial fibrillation begets trouble. Heart 1997;77:393-394.

    Google Scholar 

  17. Juul-Moller S, Edvardsson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990;82(6):1932-1939.

    Google Scholar 

  18. Vitolo E, Tronci M, LaRovere MT, Rumolo R, Morabito A. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. Acta Cardiologica 1981;36:431-444.

    Google Scholar 

  19. Steinbeck G, Greene HL. Management of patients with life-threatening sustained ventricular tachyarrhythmias; tha role of guided antiarrhythmic drug therapy. Prog Cardiovasc Dis 1996;38:419-428.

    Google Scholar 

  20. Cohen IS, Jick H, Cohen SI. Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program. Prog Cardiovasc Dis 1977;20:151-163.

    Google Scholar 

  21. Mahmarian JJ, Verani MS, Hohmann T, Hill R, Thornton BC, Bolli R, et al. The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography. Circulation 1987;76(2):324-331.

    Google Scholar 

  22. Nattel S. Antiarrhythmic drug classifications: a critical appraisal of their history, present status, and clinical relevance. Drugs 1991;41:672-701.

    Google Scholar 

  23. DiMarco JP, Garan H, Ruskin JN. Quinidine for ventricular arrhythmias: value of electrophysiologic testing. Am J Cardiol 1983;51:90-95.

    Google Scholar 

  24. Toivonen L, Kadish A, Morady F. A Prospective comparison of class IA, B and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. Circulation 1991;84:101-108.

    Google Scholar 

  25. Dorian P, Newman D, Berman N, Hardy J, Mitchell J. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia. J Am Coll Cardiol 1993; 22(1):106-113.

    Google Scholar 

  26. Maisel WH, Kuntz KM, Reimold SC, Lee TH, Antman EM, Friedman PL, et al. Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a University Hospital. Ann Int Med 1997;127:281-284.

    Google Scholar 

  27. Prystowsky EN, Benson DW, Fuster V, Hart RG, Kay GN, Myerburg RJ, et al. Management of patients with atrial fibrillation. Circulation 1996;93:1262-1277.

    Google Scholar 

  28. Sindrup SH, Brosen K, Bjerring P, Arendt-Nielsen L, Larsen U, Angelo HR, et al. The effect of quinidine on the analgesic effect of codeine. Eur J Clin Pharm 1992;42:587-592.

    Google Scholar 

  29. Benet LZ, Oie S, Schwartz JB. Design and optimization of dosage regimens; Pharmacokinetic data. In: Hardman JG, Limbird LE, ed. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996;1707-1792.

    Google Scholar 

  30. Borgeat A, Goy J-J, Maendly R, Kaufman U, Grbic M, Sigwart U. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1986;58:496-498.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Biochemistry, University of Cambridge and the Department of Cardiology, Papworth Hospital, Cambridge CB3 8RE, United Kingdom

    Andrew A. Grace

  2. Department of Cardiological Sciences, St. George's Hospital Medical School, Cranmer Terrace, London SW17 ORE, United Kingdom

    A. John Camm

Authors
  1. Andrew A. Grace
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. John Camm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grace, A.A., Camm, A.J. Quinidine in Atrial Fibrillation and Ventricular Tachycardia. Card Electrophysiol Rev 2, 207–210 (1998). https://doi.org/10.1023/A:1009940302498

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009940302498

Keywords

Search

Navigation